“In the spirit of collaboration, PulmoGeniX, Inc. and the Mayo Clinic combine their respective technologies and expertise to advance treatment and control of asthma for patients whose asthma is persistent and not well controlled.  We expect to commercialize a next generation procedure that incorporates diagnostic intelligence before and after treatment in a safe, cost effective solution.  We welcome Mayo Clinic’s participation and development, clinical investigation and study of the technology.”

 — Dr. Jerry Katzman, CEO